日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Low-level shRNA Cytotoxicity Can Contribute to MYC-induced Hepatocellular Carcinoma in Adult Mice

低水平shRNA细胞毒性可导致成年小鼠MYC诱导的肝细胞癌

Beer, Shelly; Bellovin, David I; Lee, Joyce S; Komatsubara, Kimberly; Wang, Lora S; Koh, Huishan; Börner, Kathleen; Storm, Theresa A; Davis, Corrine R; Kay, Mark A; Felsher, Dean W; Grimm, Dirk

EcDNA-borne PVT1 fusion stabilizes oncogenic mRNAs

胞外DNA携带的PVT1融合蛋白可稳定致癌mRNA

Yi, Hyerim; Zhang, Shu; Swinderman, Jason; Wang, Yanbo; Kanakaveti, Vishnupriya; Hung, King L; Wong, Ivy Tsz-Lo; Srinivasan, Suhas; Curtis, Ellis J; Bhargava-Shah, Aarohi; Li, Rui; Jones, Matthew G; Luebeck, Jens; Zhao, Yanding; Belk, Julia A; Kraft, Katerina; Shi, Quanming; Yan, Xiaowei; Pritchard, Simon K; Liang, Frances M; Felsher, Dean W; Gilbert, Luke A; Bafna, Vineet; Mischel, Paul S; Chang, Howard Y

Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual disease.

空间分析揭示了肝细胞癌微小残留病灶中可靶向的巨噬细胞介导的免疫逃逸机制

Lemaitre Lea, Adeniji Nia, Suresh Akanksha, Reguram Reshma, Zhang Josephine, Park Jangho, Reddy Amit, Trevino Alexandro E, Mayer Aaron T, Deutzmann Anja, Hansen Aida S, Tong Ling, Arjunan Vinodhini, Kambham Neeraja, Visser Brendan C, Dua Monica M, Bonham C Andrew, Kothary Nishita, D'Angio H Blaize, Preska Ryan, Rosen Yanay, Zou James, Charu Vivek, Felsher Dean W, Dhanasekaran Renumathy

A big step for MYC-targeted therapies

MYC靶向疗法的一大进步

Atibalentja, Danielle F; Deutzmann, Anja; Felsher, Dean W

Single-nucleus chromatin accessibility identifies a critical role for TWIST1 in idiopathic pulmonary fibrosis myofibroblast activity

单核染色质可及性分析揭示了TWIST1在特发性肺纤维化肌成纤维细胞活性中的关键作用

Valenzi, Eleanor; Bahudhanapati, Harinath; Tan, Jiangning; Tabib, Tracy; Sullivan, Daniel I; Nouraie, Mehdi; Sembrat, John; Fan, Li; Chen, Kong; Liu, Silvia; Rojas, Mauricio; Lafargue, Audrey; Felsher, Dean W; Tran, Phuoc T; Kass, Daniel J; Lafyatis, Robert

MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint

MYC驱动的Siglec配体合成是一种糖免疫检查点

Smith, Benjamin A H; Deutzmann, Anja; Correa, Kristina M; Delaveris, Corleone S; Dhanasekaran, Renumathy; Dove, Christopher G; Sullivan, Delaney K; Wisnovsky, Simon; Stark, Jessica C; Pluvinage, John V; Swaminathan, Srividya; Riley, Nicholas M; Rajan, Anand; Majeti, Ravindra; Felsher, Dean W; Bertozzi, Carolyn R

The MYC oncogene - the grand orchestrator of cancer growth and immune evasion

MYC癌基因——癌症生长和免疫逃逸的幕后操纵者

Dhanasekaran, Renumathy; Deutzmann, Anja; Mahauad-Fernandez, Wadie D; Hansen, Aida S; Gouw, Arvin M; Felsher, Dean W

Tackling heterogeneity in treatment-resistant breast cancer using a broad-spectrum therapeutic approach

利用广谱治疗方法应对耐药性乳腺癌的异质性

Lowe, Leroy; LaValley, J William; Felsher, Dean W

The Key Characteristics of Carcinogens: Relationship to the Hallmarks of Cancer, Relevant Biomarkers, and Assays to Measure Them

致癌物的关键特征:与癌症标志物、相关生物标志物及其检测方法的关系

Smith, Martyn T; Guyton, Kathryn Z; Kleinstreuer, Nicole; Borrel, Alexandre; Cardenas, Andres; Chiu, Weihsueh A; Felsher, Dean W; Gibbons, Catherine F; Goodson, William H 3rd; Houck, Keith A; Kane, Agnes B; La Merrill, Michele A; Lebrec, Herve; Lowe, Leroy; McHale, Cliona M; Minocherhomji, Sheroy; Rieswijk, Linda; Sandy, Martha S; Sone, Hideko; Wang, Amy; Zhang, Luoping; Zeise, Lauren; Fielden, Mark

A Tale of Two Complications of Obesity: NASH and Hepatocellular Carcinoma

肥胖的两种并发症:非酒精性脂肪性肝炎和肝细胞癌

Dhanasekaran, Renumathy; Felsher, Dean W